ICMR has released the results of the first study on the mixing of corona vaccine in the country. The study states that a mixed dose of Covaxin and Covishield provides better protection against the coronavirus. According to ICMR, it is safe to take a mixed dose of Adenoviral Vector Platform Vaccine and Inactivated Whole Virus Vaccine. Different doses of these two vaccines give better immunity than two doses of the same vaccine.
This study of corona vaccine mixing was done by ICMR in the middle of May-June in UP. The expert panel of DGCI recommended a study of mixed doses of Covishield and Covaxin. After this, Christian Medical College Vellore was also allowed a mixed trial dose of the vaccine.
In the midst of the fear of the third wave of corona in the country and the danger of the delta variant, this study is going to give a lot of relief. Mixed doses will help to overcome the shortage of vaccines. At the same time, this will also reduce the fear of adverse effects in people from different vaccine doses.
Emergency use approval has been given to Johnson & Johnson's single-dose vaccine in the country only last week. This is the 5th vaccine to get emergency use approval in the country after Covishield, Covaxin, Sputnik V and Moderna. In an earlier study by ICMR, Bharat Biotech's Covaxin was shown to be effective against the delta variant of Corona.
According to the data of the Ministry of Health, so far a total of 3 crores 19 lakh 34 thousand 455 cases of corona have been reported in India. Whereas, a total of 4 lakh 27 thousand 862 people have lost their lives with 491 new deaths in the last 24 hours. At present, the number of active cases in the country has come down to 4 lakh 6 thousand 822.
Like and Follow us on :
